KR20180086508A - 치환된 5,6-디하이드로-6-페닐벤조[f]이소퀴놀린-2-아민 화합물의 고체 형태 - Google Patents
치환된 5,6-디하이드로-6-페닐벤조[f]이소퀴놀린-2-아민 화합물의 고체 형태 Download PDFInfo
- Publication number
- KR20180086508A KR20180086508A KR1020187020340A KR20187020340A KR20180086508A KR 20180086508 A KR20180086508 A KR 20180086508A KR 1020187020340 A KR1020187020340 A KR 1020187020340A KR 20187020340 A KR20187020340 A KR 20187020340A KR 20180086508 A KR20180086508 A KR 20180086508A
- Authority
- KR
- South Korea
- Prior art keywords
- powder diffraction
- ray powder
- diffraction pattern
- polymorph
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/78—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 2
- C07D239/84—Nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Quinoline Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562268747P | 2015-12-17 | 2015-12-17 | |
| US62/268,747 | 2015-12-17 | ||
| PCT/US2016/067164 WO2017106642A1 (en) | 2015-12-17 | 2016-12-16 | Solid forms of substituted 5,6-dihydro-6-phenylbenzo[f]isoquinolin-2-amine compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR20180086508A true KR20180086508A (ko) | 2018-07-31 |
Family
ID=59057612
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020187020340A Ceased KR20180086508A (ko) | 2015-12-17 | 2016-12-16 | 치환된 5,6-디하이드로-6-페닐벤조[f]이소퀴놀린-2-아민 화합물의 고체 형태 |
Country Status (19)
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2017106642A1 (en) * | 2015-12-17 | 2017-06-22 | Arqule, Inc. | Solid forms of substituted 5,6-dihydro-6-phenylbenzo[f]isoquinolin-2-amine compounds |
| MX2020012771A (es) | 2015-12-17 | 2022-10-04 | Arqule Inc | Metodos para preparar 5,6-dihidro-6-fenilbenzo[f]isoquinolin-2-ami na sustituida. |
| WO2022053708A1 (en) | 2020-09-14 | 2022-03-17 | Basilea Pharmaceutica International AG | Pharmaceutical combinations for use in the treatment of gastric adenocarcinoma |
| JP7641247B2 (ja) | 2022-03-02 | 2025-03-06 | 日立建機株式会社 | 機械の性能診断装置 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4522811A (en) | 1982-07-08 | 1985-06-11 | Syntex (U.S.A.) Inc. | Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides |
| AU5330698A (en) * | 1996-12-23 | 1998-07-17 | Celltech Therapeutics Limited | Fused polycyclic 2-aminopyrimidine derivatives, their preparation and their use as protein tyrosine kinase inhibitors |
| GB9713087D0 (en) * | 1997-06-20 | 1997-08-27 | Celltech Therapeutics Ltd | Chemical compounds |
| EP1790634A3 (en) * | 2003-06-18 | 2007-06-13 | Teva Pharmaceutical Industries Ltd. | Fluvastatin sodium crystal form and processes for preparing it |
| CA2710051C (en) * | 2006-12-29 | 2017-05-16 | Rigel Pharmaceuticals, Inc. | Substituted triazoles useful as axl inhibitors |
| CN102325755B (zh) * | 2008-12-30 | 2015-07-01 | 艾科尔公司 | 取代的5,6-二氢-6-苯基苯并[f]异喹啉-2-胺化合物 |
| JP5808818B2 (ja) * | 2010-11-25 | 2015-11-10 | ラツィオファーム・ゲーエムベーハー | アファチニブの新規塩及び多形形態 |
| WO2012177852A1 (en) | 2011-06-24 | 2012-12-27 | Arqule, Inc | Substituted imidazopyridinyl compounds |
| US9802954B2 (en) * | 2011-08-24 | 2017-10-31 | Boehringer Ingelheim International Gmbh | Piperidino-dihydrothienopyrimidine sulfoxides and their use for treating COPD and asthma |
| WO2013044816A1 (en) * | 2011-09-30 | 2013-04-04 | Sunshine Lake Pharma Co., Ltd. | Crystalline forms of azilsartan and preparation and uses thereof |
| WO2017106642A1 (en) * | 2015-12-17 | 2017-06-22 | Arqule, Inc. | Solid forms of substituted 5,6-dihydro-6-phenylbenzo[f]isoquinolin-2-amine compounds |
| MX2020012771A (es) * | 2015-12-17 | 2022-10-04 | Arqule Inc | Metodos para preparar 5,6-dihidro-6-fenilbenzo[f]isoquinolin-2-ami na sustituida. |
| US9847831B2 (en) | 2016-04-08 | 2017-12-19 | Ciena Corporation | Dual wavelenth optical time domain reflectometer systems and methods embedded in a WDM system |
-
2016
- 2016-12-16 WO PCT/US2016/067164 patent/WO2017106642A1/en not_active Ceased
- 2016-12-16 MX MX2018007414A patent/MX385671B/es unknown
- 2016-12-16 IL IL259556A patent/IL259556B2/en unknown
- 2016-12-16 CA CA3006081A patent/CA3006081A1/en active Pending
- 2016-12-16 EA EA202091691A patent/EA202091691A1/ru unknown
- 2016-12-16 MX MX2021000432A patent/MX394320B/es unknown
- 2016-12-16 US US15/381,414 patent/US9981921B2/en active Active
- 2016-12-16 TW TW111124239A patent/TWI796250B/zh not_active IP Right Cessation
- 2016-12-16 AU AU2016369523A patent/AU2016369523B2/en not_active Ceased
- 2016-12-16 JP JP2018531388A patent/JP2018537499A/ja active Pending
- 2016-12-16 TW TW105141873A patent/TWI771280B/zh not_active IP Right Cessation
- 2016-12-16 CN CN201680073181.8A patent/CN108368061A/zh active Pending
- 2016-12-16 SG SG11201804670PA patent/SG11201804670PA/en unknown
- 2016-12-16 NZ NZ742695A patent/NZ742695A/en not_active IP Right Cessation
- 2016-12-16 EP EP16876769.7A patent/EP3390369B1/en active Active
- 2016-12-16 HK HK18115910.5A patent/HK1256825A1/zh unknown
- 2016-12-16 EA EA201891430A patent/EA036295B1/ru unknown
- 2016-12-16 KR KR1020187020340A patent/KR20180086508A/ko not_active Ceased
- 2016-12-16 ES ES16876769T patent/ES2935818T3/es active Active
- 2016-12-16 BR BR112018012095A patent/BR112018012095A2/pt not_active Application Discontinuation
- 2016-12-16 EP EP21216052.7A patent/EP4019499A1/en active Pending
-
2018
- 2018-04-30 US US15/966,091 patent/US10227311B2/en active Active
- 2018-06-13 SA SA518391805A patent/SA518391805B1/ar unknown
- 2018-06-13 PH PH12018501246A patent/PH12018501246A1/en unknown
-
2019
- 2019-01-30 US US16/261,744 patent/US10717710B2/en not_active Expired - Fee Related
-
2020
- 2020-09-14 PH PH12020551465A patent/PH12020551465A1/en unknown
-
2021
- 2021-11-26 JP JP2021191696A patent/JP2022031797A/ja active Pending
-
2022
- 2022-03-21 AU AU2022201947A patent/AU2022201947B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR102965826B1 (ko) | 헤테로고리 화합물, 이의 제조 방법 및 이의 용도 | |
| TWI675839B (zh) | 一種jak激酶抑制劑的硫酸氫鹽的結晶形式及其製備方法 | |
| AU2022201947B2 (en) | Solid forms of substituted 5,6-dihydro-6-phenylbenzo[f]isoquinolin-2-amine compounds | |
| CA3043772C (en) | Hydrates of 2,4,6-trifluoro-n-[6-(1-methyl-piperidine-4-carbonyl)-pyridin-2-yl]-benzamide hemisuccinate, and uses thereof as a 5-ht1f agonist | |
| AU2016369835A1 (en) | Pyrido[1,2-a]pyrimidone analog, crystal form thereof, intermediate thereof and preparation method therefor | |
| CN111278808B (zh) | 2-(5-(4-(2-吗啉代乙氧基)苯基)吡啶-2-基)-n-苄基乙酰胺的固体形式 | |
| TWI820182B (zh) | 四氫哌喃基胺基-吡咯并嘧啶酮化合物的固體形式 | |
| CN114026088A (zh) | Jak2抑制剂的结晶形式 | |
| JP2017513890A (ja) | 置換されたイミダゾピリジニル−アミノピリジン化合物の塩および多型 | |
| HK40079038A (en) | Method of preparing solid forms of substituted 5,6-dihydro-6-phenylbenzo[f]isoquinolin-2-amine compounds | |
| US20240239796A1 (en) | Crystalline polymorphs of epidermal growth factor receptor inhibitor, and compositions and methods thereof | |
| TW202342041A (zh) | 一種藥物組合物及所含活性成分化合物的製備方法 | |
| EA044678B1 (ru) | СПОСОБ ПОЛУЧЕНИЯ ПОЛИМОРФНОЙ ФОРМЫ СОЕДИНЕНИЯ ДИГИДРОХЛОРИДА (R)-6-(2-ФТОРФЕНИЛ)-N-(3-(2-(2-МЕТОКСИЭТИЛАМИНО)ЭТИЛ)ФЕНИЛ)-5,6-ДИГИДРОБЕНЗО[h]ХИНАЗОЛИН-2-АМИНА | |
| EA045924B1 (ru) | Кристаллическая форма моногидрата 1-(1-оксо-1,2-дигидроизохинолин-5-ил)-5-(трифторметил)-n-(2-(трифторметил)пиридин-4-ил)-1h-пиразол-4-карбоксамида |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0105 | International application |
Patent event date: 20180716 Patent event code: PA01051R01D Comment text: International Patent Application |
|
| PG1501 | Laying open of application | ||
| A201 | Request for examination | ||
| PA0201 | Request for examination |
Patent event code: PA02012R01D Patent event date: 20211209 Comment text: Request for Examination of Application |
|
| E902 | Notification of reason for refusal | ||
| PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20231215 Patent event code: PE09021S01D |
|
| E601 | Decision to refuse application | ||
| PE0601 | Decision on rejection of patent |
Patent event date: 20240223 Comment text: Decision to Refuse Application Patent event code: PE06012S01D Patent event date: 20231215 Comment text: Notification of reason for refusal Patent event code: PE06011S01I |